INCONTRO CON L’ESPERTO Capire e riconoscere le sepsi Gianni Biolo

1. Pneumo Trieste 16-18 Aprile 2018 INCONTRO CON L’ESPERTO Capire e riconoscere le sepsi Gianni Biolo Dipartimento di Scienze Mediche Chirurgiche e della Salute Clinica Medica Generale e Terapia Medica Università di Trieste Azienda sanitaria Universitaria Integrata di Trieste - ASUITs

2. The host response to infection and during sepsis DYSREGULATED HOST RESPONSE LIFE THREATENING ORGAN DYSFUNCTIONC NATURE REVIEWS | IMMUNOLOGY 2017 doi:10.1038/nri.2017.36

3. Current conceptual model of outcomes of sepsis. Originally conceived by Bone et al. in the 1990s, the current model of the clinical trajectory that patients traverse in sepsis has evolved to reflect the concurrent inflammatory and immunosuppressive responses, and the observation that fewer patients are dying in the early period owing to earlier recognition and better implementation of best clinical practices. Successful resuscitation is occurring more frequently and the patients recover sufficiently to be discharged from the intensive care unit and hospital (blue lines). Some patients experience a pronounced early inflammatory response to the pathogen or danger signals, leading to multiple organ failure and death (red line). Other patients survive the early inflammatory response but experience chronic critical illness (green lines) that is characterized by persistent inflammation, immunosuppression and catabolism syndrome (PICS); reactivation of latent viral infections; nosocomial infections; and long-term functional and cognitive declines. DAMP, damage-associated molecular pattern; DC, dendritic cell; MDSC, myeloid-derived suppressor cell; NO, nitric oxide; ROS, reactive oxygen species; TH2, T helper 2. NATURE REVIEWS | DISEASE PRIMERS Article number: 16045 doi:10.1038/nrdp.2016.45 Published online 30 June 2016

4. Acute kidney injury in a patient with pneumonia A 72-year-old woman with chronic obstructive pulmonary disease (COPD) on home oxygen, and coronary artery disease presented to the hospital with shortness of breath. She had been hospitalized for an exacerbation of her COPD 2 weeks prior but had been doing well at home on home oxygen. In the emergency department, she was ill appearing and in some respiratory distress. Her vital signs were notable for a temperature of 38.6° C, heart rate of 115 beats per minute, blood pressure of 114/68 mm Hg, respiratory rate of 28 breaths per minute, and PaO2of 53 mm Hg on her baseline 2 liters/min 28% (=189 PaO2/FiO2). She was found to have decreased breath sounds at the left base and appeared dehydrated. She had a white blood cell count of 21.4 x 103/mL, creatinine of 2.1 mg/dL (up from a baseline of 1.3 mg/dL), a lactate of 3.9 mmol/L (nv<2; septic shock >4; conversion 1 mmol/L = 9 mg/dl) and an international normalized ratio (INR) of 1.5, platelet count of 150 x 103/mL. A chest radiograph revealed an infiltrate in the left lower lobe and she was diagnosed with pneumonia complicated by sepsis and acute kidney injury. https://psnet.ahrq.gov/webmm/case/347/errors-in-sepsis-management SIRS SOFA Sequential [Sepsis-Related] Organ Failure Assessment Score

5. Sepsis Definition 1991 1,171,797 patients 172 Australia-New Zealand ICUs 2000-2013 109,663 Severe sepsis (infection + organfailure) 13,278 (12%) SIRS - 96,385 (88%) SIRS + SIRS attracted criticism for lack of specificity (e.g. a young patient with fever and tachycardia in the context of a viral respiratory infection was determined to have ‘sepsis’) as well as imperfect sensitivity. One study found 12% of ICU patients with infection and organ dysfunction did not have SIRS. Bellomo et al., doi: 10.1111/1742-6723.12886 Systemic Inflammatory Response Syndrome Criteria in Defining Severe Sepsis NEJM April 23, 2015

6. Sepsis Definition 2001 Predictive capability of diagnostic criteria in sepsis diagnosis (multivariate logistic regression analysis) An evaluation of the diagnostic accuracy of the 1991 American College of Chest Physicians/Society of Critical Care Medicine and the 2001 Society of Critical Care Medicine/European Society of Intensive Care Medicine/American College of Chest Physicians/American Thoracic Society/Surgical Infection Society sepsis definition. Crit Care Med 2012; 40: 1700–1706

7. Risk factors for developing sepsis Age Very young (<2 years of age) >55 years of age Chronic and serious illness Cancer Diabetes Chronic obstructive pulmonary disease Cirrhosis or biliary obstruction Cystic fibrosis Chronic kidney disease Congestive heart failure Collagen vascular disease Obesity‡ Impaired immunity Transplantation Chemotherapy Radiation therapy Drug-mediated immune suppression Blood transfusions Breach of natural barriers Trauma Surgical injury Catheterization or intubation Burns Enterocolitis Chronic infections HIV Urinary tract infections Pneumonia Decubitus or non-healing dermal wounds Other Protein calorie malnutrition Benchmarking the Incidence and Mortality of Severe Sepsis in the United States Crit Care Med 2013; 41:1167-1174 • Yearly incidence according to different studies and methods: Angus et al 905/100,000,Wang et al 1,031/100,000, Dombrovskiy et al 300/100,000, and Martin et al 369/100,000. • Regardless of method, there was a steady increase in the annual incidence and average annual percentage increase in the incidence was similar: 13.0% for both Angus et al and Wang et al and 13.3% for both Dombrovskiy et al and Martin et al.

8. Lancet Infect Dis 2012;12:919-24 Trajectories ICU Outcomes 28% 41%

9. Intensive Care Med 2014 DOI 10.1007/s00134-014-3496-0 Updated Bundles 2015 29,470 subjects, 218 sites (EU, US, South America), 2005-2012. Resuscitation and Surviving Sepsis Campaign (SSC) bundle compliance and hospital mortality. Overall lower mortality was observed in high (29.0 %) versus low (38.6 %) resuscitation bundle compliance sites (p<0.001) (i.e., 25% relative risk reduction in mortality rate). The timing of early antibiotics and hospital mortality in sepsis Am J Respir Crit Care Med. 2017 doi: 10.1164/rccm.201609-1848OC

10. Acute kidney injury in a patient with pneumonia A 72-year-old woman with chronic obstructive pulmonary disease (COPD) on home oxygen, and coronary artery disease presented to the hospital with shortness of breath. She had been hospitalized for an exacerbation of her COPD 2 weeks prior but had been doing well at home on home oxygen. In the emergency department, she was ill appearing and in some respiratory distress. Her vital signs were notable for a temperature of 38.6° C, heart rate of 115 beats per minute, blood pressure of 114/68 mm Hg, respiratory rate of 28 breaths per minute, and PaO2of 53 mm Hg on her baseline 2 liters/min 28% (=189 PaO2/FiO2). She was found to have decreased breath sounds at the left base and appeared dehydrated. She had a white blood cell count of 21.4 x 103/mL, creatinine of 2.1 mg/dL (up from a baseline of 1.3 mg/dL), a lactate of 3.9 mmol/L (nv<2; septic shock >4; conversion 1 mmol/L = 9 mg/dl) and an international normalized ratio (INR) of 1.5, platelet count of 150 x 103/mL. A chest radiograph revealed an infiltrate in the left lower lobe and she was diagnosed with pneumonia complicated by sepsis and acute kidney injury. The patient was given 1 liter of normal saline in the emergency department. However, because of her history of coronary artery disease, she was not given any additional intravenous fluids. Blood cultures were drawn, and she received levofloxacin (administered approximately 6 hours after presentation). She was admitted to the transitional care unit but slowly worsened. Twenty-four hours after admission, her blood cultures were growing methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin was added to her antibiotic regimen. Despite the antibiotics and additional intravenous fluids, she continued to deteriorate. The patient developed respiratory failure requiring mechanical ventilation as well as septic shock requiring vasopressors. Her illness progressed and in discussions with her family, the decision was made to withdraw life-sustaining therapies. She died on hospital day 4 with her family at her bedside. https://psnet.ahrq.gov/webmm/case/347/errors-in-sepsis-management SIRS SOFA Sequential [Sepsis-Related] Organ Failure Assessment Score

11. Intensive Care Med 2014 DOI 10.1007/s00134-014-3496-0 Updated Bundles 2015 29,470 subjects, 218 sites (EU, US, South America), 2005-2012. Resuscitation and Surviving Sepsis Campaign (SSC) bundle compliance and hospital mortality. Overall lower mortality was observed in high (29.0 %) versus low (38.6 %) resuscitation bundle compliance sites (p<0.001) (i.e., 25% relative risk reduction in mortality rate). Comitato Infezioni Ospedaliere, ASUITs 2015/2016 PROTOCOLLI DI TERAPIA ANTIBIOTICA EMPIRICA RAGIONATA POLMONITI The timing of early antibiotics and hospital mortality in sepsis Am J Respir Crit Care Med. 2017 doi: 10.1164/rccm.201609-1848OC

12. SIRS

13. Sepsis Definition 2016 Singer, M. et al. The third international consensus definitions for sepsis and septic shock (Sepsis‑3). JAMA 315, 801–810 (2016).

14. Sequential [Sepsis-Related] Organ Failure Assessment Score Abbreviations: FIO2, fraction of inspired oxygen; MAP, mean arterial pressure; PaO2, partial pressure of oxygen. b catecholamine doses are given as μg/kg/min for at least 1 hour. c Glasgow Coma Scale scores range from 3-15; higher score indicates better neurological function.c Singer, M. et al. The third international consensus definitions for sepsis and septic shock (Sepsis‑3). JAMA 315, 801–810 (2016).

15. Operationalization of Clinical Criteria Identifying Patients With Sepsis and Septic Shock The baseline Sequential [Sepsis-related] Organ Failure Assessment (SOFA) score should be assumed to be zero unless the patient is known to have preexisting (acute or chronic) organ dysfunction before the onset of infection. qSOFA indicates quick SOFA; MAP, mean arterial pressure. Singer, M. et al. The third international consensus definitions for sepsis and septic shock (Sepsis‑3). JAMA 315, 801–810 (2016).

16. DIAGNOSIS PROGNOSIS A Comparison of the Quick-SOFA and Systemic Inflammatory Response Syndrome Criteria for the Diagnosis of Sepsis and Prediction of Mortality A Systematic Review and Meta-Analysis CHEST 2018; 153(3):646-655

17. … “the original intention of qSOFA was to identify infection…but further studies focus on prognosis rather than diagnosis...” … “ to identify infection… rely on clinical judgment”… January 17, 2017, Volume 137, 267-28 Prognostic Accuracy of Sepsis-3 Criteria for In-Hospital Mortality Among Patients With Suspected Infection Presenting to the Emergency Department

18. = 0.28 Cohen's kappa coefficient measures inter-rater agreement (concordance) for categorical items

19. TYPICAL PRESENTATION

20. ATYPICAL PRESENTATION Fever < 38°C and/or WBC< 12000/mm3 Age > 65 + multiple comorbidities • Microbiologicaldocumentation • Riskfactorsfor MDR • Chance ofstewardship • Resistance • Mortality

21. Prevalence of infection ̴ 5:1 • Aspiration • Anaphylaxis • Adrenalinsufficency • Bowelobstruction • Diabeticketoacidosis • Heatemergency • Hypovolemia • PulmonaryEmbolism • Pancreatitis • Heatemergency • Intestinal ischemia • Tyroiddisease • Toxicingestion/overdose • Withdrawl state • Spinalcordinjury • Cancer • PATIENTS • 45% had positive culture results • 55% had negative culture results. • 24% had clinical infections • 4% had atypical infections • 18% had noninfectious mimics • 9% had an illness of indeterminate etiology 2010; 50:814–820

22. Is the patientinfected? 70% 20% YES NO 10% • Missed or delayed antibiotic therapy • Inappropriate antibiotic therapy DEBATABLE

23. Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting Intensive Care Medicine 2015 DOI: 10.1007/s00134-015-3978-8 Causes and consequences of heavy antibiotic use

24. BIOMARKERS • Fast kinetics • High sensitivity and specificty • Fully automated technology • Short turn around time • Availability as point of care • Low cost

25. Mearelli et al., Infection. 2015 Is the patient infected?Sepsis Biomarkers! soluble triggering receptor expressed on myeloid cells 1 pancreatic stone protein heparin binding protein

26. PROCALCITONIN (PCT) DIAGNOSIS STEWARDSHIP AUC 0.85 pooled Sn 77, Sp 79 bacterial Sn 88, Sp 81 = mortality antibiotic consumption Costs? AE and resistance?

27. PRETEST PROBABILITY CLINICAL DECISION RULES FOR THE EVALUATION OF PRETEST PROBABILITY OF PULMONARY EMBOLISM IN HEMODYNAMICALLY STABLE PATIENTS • sudden onset of dyspnoea • pleuritic chest pain • haemoptysis • extremity swelling suggestive of DVT • syncope

28. “Derivation and validation of a biomarker-based clinical algorithm to rule out sepsis from non-infectious systemic inflammatory response syndrome at Emergency Department admission: a multicenter prospective study”. Filippo Mearelli1 MD, Nicola Fiotti1 MD, Carlo Giansante1 MD, Chiara Casarsa1 MD, Daniele Orso1 MD, Marco De Helmersen1MD, Nicola Altamura1 MD, Maurizio Ruscio7 MD, Luigi Mario Castello2 MD, Efrem Colonnetti5 MD, Rossella Marino3 MD, Giulia Barbati1 PHD, Andrea Bregnocchi MD8, Claudio Ronco6 MD, Enrico Lupia4 MD, Giuseppe Montrucchio4 MD, Maria Lorenza Muiesan5 MD, Salvatore Di Somma3 MD, Gian Carlo Avanzi2 MD & Gianni Biolo1 MD. Internal Medicine, Department of MedicalSurgical and HealthSciences-University of Trieste, Trieste, Italy Emergency Medicine, Department of Translational Medicine EasternPiedmont-University of Novara, Novara, Italy Emergency Medicine, Department of MedicalSurgerySciences and Translational medicine-University “Sapienza” of Rome, Rome, Italy Emergency Medicine, Department of MedicalSciences-University of Turin, Turin, Italy Internal Medicine, Department Of Clinical And ExperimentalSciences-University Of Brescia, Brescia, Italy Department of Nephrology, Dialysis and Transplantation International RenalResearchInstitute St Bortolo Hospital, Vicenza, Italy Department of Chemical and PharmaceuticalSciences-University of Trieste, Trieste, Italy Internal Medicine, General Hospital of Susa, Susa (TO), Italy 2018

29. OBJECTIVE: to derive and validate an Experimental algorithm integrating a nomogram-based prediction of the pre-test probability of infection with a panel of serum biomarkers, which could robustly rule out sepsis/septic shock from non-infectious-SIRS. DESIGN: multicenter prospective study. SETTING: at Emergency Department admission in five University Hospitals. PATIENTS: 1132 consecutive patients with SIRS 947 adults in inception cohort 185 adults in validation cohort. Mearelli et al. Crit Care Med 2018

30. Nomogram-based prediction of pre-test probability of infection Infection probability Mearelli et al. Crit Care Med 2018

31. BIOMARKERS • Procalcitonin (PCT) • SolubleTriggeringreceptorexpressed on myeloid cell-1 (sTREM-19) • SolublePhospholypase A2 Group IIA (sPLA2GIIA) • Soluble IL-2 receptorα, (sCD25) • Presepsin (CD14-st) Mearelli et al., Infection. 2015

32. INCEPTION COHORT Receiver operating characteristic curves of biomarkers to diagnose infection in all of its spectrum of severity in Group1 and Group 2.

33. INCEPTION COHORT < 1/3 !!! The NPV and PPV of the Experimental algorithm for diagnosing infection in the full spectrum of severity were 71% and 93%, respectively. The corresponding figure for the diagnosis of S/SS were 93% and 92%, respectively.

34. Experimental algorithm: final adjudication of the patients enrolled in inception and validation cohort Inception vs validation cohort: comparison of false negative and false positive results In the whole population (1161 patients with SIRS), only 5 (0.7%) patients with S/SS were misclassified

35. CONCLUSIONI • La diagnosi di sepsi è complessa • Il qSOFA non supporta il processo decisionale meglio dei criteri di SIRS • Per poter valutare la performance dei marcatori nella diagnosi di sepsi è indispensabile quantificare in modo riproducibile la probabilità pretest di infezione

36. CONCLUSIONI • La combinazione di PCT e PLA2GII nei pazienti a non alta probabilità di infezione esclude la sepsi con un VPN del 93%. • La popolazione da testare per ottenere questo risultato è < 1/3.